5M Biomed, LLC

Alpharetta, GA

UEI
K82GCNF5EPU3
CAGE
8DVT9
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
670 Lake Medlock Dr, Alpharetta, GA 30022, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Multi-functional magnetic nanorods for constructing theranostic extracellular vesicles for treating myocardial… R41HL169102 National Heart Lung and Blood Institute (NIH) $306,433
Development of "imagnostix": a liquid biopsy system for alzheimer's disease R42AG078718 National Institute on Aging (NIH) $1,700,136
Highly sensitive and robust blood test platform for screening and early detection of alzheimer's disease - with an… R43AG078718 National Institute on Aging (NIH) $799,680
Small intestine targeted fast acting oral insulin formulation R41DK131761 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $899,793
A new class of magnetic nanoparticles for glioma targeted drug delivery R41CA261544 National Cancer Institute (NIH) $1,200,000

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Optimeos Life Sciences, Inc. UEI LSBKUFPKAHW7 Princeton, NJ —
Fibroplate Inc. UEI UKBYP1UTHBK1 Las Vegas, NV 325414 Biological Product (except Diagnostic) Manufacturing
Superior Nano LLC UEI J1A3A7S6J4H7 Saint Paul, MN 325412 Pharmaceutical Preparation Manufacturing
Theranostec Inc. UEI C1B4H9JHQ3J6 Carmichael, CA 541713 Research and Development in Nanotechnology
Nostopharma LLC UEI FKVPNPQK64H8 Rockville, MD 541713 Research and Development in Nanotechnology

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

5M Biomed, LLC, registered in SAM.gov as a for-profit organization and manufacturer of biomedical goods, develops innovative nanotechnology platforms and nanoformulations for medical applications. Its core competencies lie in engineering multifunctional magnetic nanoparticles and targeted nanocarriers for therapeutics, diagnostics, and theranostics.

Through several prime federal grants, 5M Biomed has provided nanomedicine research and development services across multiple disease areas. It has received awards from NIH institutes like NHLBI, NCI, NIA, and NIDDK to advance magnetic nanoparticle-enabled platforms for treating cardiovascular diseases (myocardial infarction), cancers (glioblastoma, medulloblastoma), neurodegenerative disorders (Alzheimer's), and metabolic conditions (diabetes). Projects involve developing theranostic nanoparticles for targeted drug delivery, non-invasive disease monitoring via MRI, and early biomarker detection from liquid biopsies. 5M Biomed collaborates with academic partners such as Johns Hopkins University and the Kennedy Krieger Institute on integrated nanotechnology solutions spanning therapeutic nanocarriers, molecular imaging agents, and multi-analyte biomarker assays. Its innovative technologies leverage magnetic nanoparticles with unique capabilities like MRI contrast, magnetic enrichment/purification, and magnetic navigation for improved treatment outcomes.

Quick answers

Is 5M Biomed, LLC registered in SAM.gov?

Yes. 5M Biomed, LLC's SAM.gov registration is active through May 12, 2027.

What is 5M Biomed, LLC's most recent federal award?

5M Biomed, LLC's most recent federal grant award is Multi-functional magnetic nanorods for constructing theranostic extracellular vesicles for treating myocardial… (R41HL169102), from National Heart Lung and Blood Institute (NIH), on December 1, 2023.

On GovTribe

See 5M Biomed, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login